Celltrion Healthcare, Stock Price Down 1.33% at This Time... Foreigners Net Buy 273,813 Shares in Last 5 Days

As of 9:30 AM on the 19th, Celltrion Healthcare is trading at 104,000 KRW, down 1.33% from the previous day. The trading volume is 365,161 shares, which is 24.89% of the previous day's volume. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.

On June 17, researcher Lee Dal-mi from SK Securities stated, "In the second half of 2020, full-scale sales of Truxima and Herzuma are expected in the U.S. market. Additionally, Inflectra, after being registered with UHC, is projected to maintain stable sales. Since both Truxima and Herzuma are anticancer drugs with high profit margins, the improvement in profitability from these two products is expected to continue in the second half of the year." He set the target price for Celltrion Healthcare at 140,000 KRW.

Over the past five days, individual investors have net sold 190,841 shares of Celltrion Healthcare, while foreigners and institutions have net bought 273,813 shares and net sold 97,246 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.